Understanding the Rise of US Liver Disease and Pancreatitis During COVID-19
US Liver Disease and COVID-19 Impact
US liver disease has seen a significant increase amid the COVID-19 pandemic. From 2006 to 2019, age-adjusted mortality rates for liver disease rose by 14%, but the number spiked by 24% during the pandemic years, from 2019 to 2021.
Surge in Pancreatitis Cases
- Contributing factors include increased alcohol consumption.
- Healthcare systems experienced strain during the pandemic, delaying treatments.
- Education on liver health appears to be critical.
This surge in liver disease and pancreatitis represents a health crisis needing immediate action.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.